Wikidata

(Q57565209)

English

Low-Activity V89L Variant in SRD5A2 Is Associated with Aggressive Prostate Cancer Risk: An Explanation for the Adverse Effects Observed in Chemoprevention Trials Using 5-Alpha-Reductase Inhibitors

scientific article published on 13 April 2007

In more languages

Statements

title
Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17448593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17448593%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 December 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q57565209&oldid=2102712675"